In age-related neurodegenerative pathologies like Alzheimer’s disease (AD), the amyloid-β (Aβ) clearance decreased due to P-glycoprotein (P-gp) dysfunction, leading to higher brain exposure. This evidence concerns the gene ABCB1 and early-onset autosomal dominant Alzheimer disease.